Sarcoma News

The FDA approved the FoundationOne CDx test to help identify certain neurotrophic receptor tyrosine kinase gene fusions in patients with solid tumors eligible for treatment with larotrectinib, according to a press release from the agency.

The prognosis typically is poor for patients with metastatic rhabdomyosarcoma.

Renowned cancer researcher Steven A. Rosenberg, MD, PhD, has been awarded the 2020 Samuel D. Gross Prize for surgical research.

Jae Jung, PhD, has been appointed chair of Cleveland Clinic Lerner Research Institute’s department of cancer biology.

Black children with solid cancers appeared less likely to receive proton radiotherapy than their white counterparts, according to an analysis of Children’s Oncology Group trial data published in a research letter in JAMA Oncology.

Tumor rupture appeared associated with shorter OS among patients treated with or without imatinib after surgery for gastrointestinal stromal tumors, or GIST, according to results of a post-hoc observational study published in JAMA Surgery.

Young adults with early-onset cancers appeared at increased risk for harboring specific germline mutations, according to study results presented at the American Association for Cancer Research Virtual Annual Meeting II.

An extended course of imatinib increased OS among patients with gastrointestinal stromal tumors, or GIST, according to long-term study results presented during the ASCO20 Virtual Scientific Program.

Doxorubicin in combination with trabectedin appeared to be an effective and safe first-line therapy for metastatic leiomyosarcoma, according to results of the phase 2 LMS-02 study presented during the ASCO20 Virtual Scientific Program.

The FDA granted accelerated approval to pomalidomide for treatment of two forms of Kaposi sarcoma.